RBP4 and metabolic dysfunction-associated steatotic liver disease: According to a prospective longitudinal study including 2,658 participants (24), higher serum VA level was associated with the progression of NAFLD, which was possibly attributed to increased triglycerides, insulin resistance, serum retinol-binding protein 4, and BMI.